ישראל -
עברית -
Ministry of Health
cellculturemedia for ivf,art,et and sperm laboratories
דבורה חסון - מומחה
ישראל -
עברית -
Ministry of Health
מדיקינט mr כמוסות בשחרור מושהה 20 מ"ג
mediline ltd. - methylphenidate hydrochloride 20 mg - modified release capsules - methylphenidate - medikinet modified release capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (adhd) in children over 6 years of age when remedial measures alone prove insufficient. treatment must be under the supervision of a specialist in childhood behavioural disorders. diagnosis should be made according to dsm-iv criteria or the guidelines in icd-10.
ישראל -
עברית -
Ministry of Health
מודיקיט mr כמוסות בשחרור מושהה 30 מ"ג
mediline ltd. - methylphenidate hydrochloride 30 mg - modified release capsules - methylphenidate - medikinet modified release capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (adhd) in children over 6 years of age when remedial measures alone prove insufficient.treatment must be under the supervision of a specialist in childhood behavioural disorders. diagnosis should be made according to dsm-iv criteria or the guidelines in icd-10.
ישראל -
עברית -
Ministry of Health
מדיקינט mr כמוסות בשחרור מושהה 40 מ"ג
mediline ltd. - methylphenidate hydrochloride 40 mg - modified release capsules - methylphenidate - medikinet modified release capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (adhd) in children over 6 years of age when remedial measures alone prove insufficient. treatment must be under the supervision of a specialist in childhood behavioural disorders. diagnosis should be made according to dsm-iv criteria or the guidelines in icd-10.
ישראל -
עברית -
Ministry of Health
ארומזין
pfizer pfe pharmaceuticals israel ltd - exemestane - טבליות מצופות - exemestane 25 mg - exemestane - exemestane - aromasin is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. aromasin is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.
ישראל -
עברית -
Ministry of Health
קלינולאיק 20%
remedix care ltd - olive oil; soya oil - תחליב לאינפוזיה - olive oil 80 %; soya oil 20 % - oil - oil - source of lipids during parenteral nutrition in situations where oral or enteral feeding is impossible, insufficient or contra-indicated.
ישראל -
עברית -
Ministry of Health
טריומל פריפרי 4 גרם חנקןליטר 700 קקלליטר עם אלקטרוליטים
remedix care ltd - alanine; arginine; aspartic acid; calcium chloride dihydrate; glucose monohydrate; glutamic acid; glycine; histidine; isoleucine; leucine; lysine; magnesium chloride; methionine; phenylalanine; potassium chloride; proline; serine; sodium acetate trihydrate; sodium glycerophosphate hydrate; soya bean oil refined + olive oil refined; threonine; tryptophan; tyrosine; valine - תחליב לאינפוזיה - alanine 9.16 g / 1 l; arginine 6.20 g / 1 l; aspartic acid 1.83 g / 1 l; glutamic acid 3.16 g / 1 l; glycine 4.39 g / 1 l; histidine 3.77 g / 1 l; isoleucine 3.16 g / 1 l; leucine 4.39 g / 1 l; lysine 4.98 g / 1 l; methionine 3.16 g / 1 l; phenylalanine 4.39 g / 1 l; proline 3.77 g / 1 l; serine 2.50 g / 1 l; threonine 3.16 g / 1 l; tryptophan 1.06 g / 1 l; tyrosine 0.16 g / 1 l; valine 4.05 g / 1 l; sodium acetate trihydrate 2.89 g / 1 l; potassium chloride 2.98 g / 1 l; magnesium chloride 1.12 g / 1 l; sodium glycerophosphate hydrate 4.78 g / 1 l; soya bean oil refined + olive oil refined 150 g / 1 l; calcium chloride dihydrate 0.74 g / 1 l; glucose monohydrate 206.25 g / 1 l - combinations - combinations - triomel is indicated for parenteral nutrition for adults and children above 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.